TOFACITINIB

13404 reported adverse events

Drug classes: Janus Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking TOFACITINIB:

# Side effect Count
0 DRUG INEFFECTIVE 3074
1 OFF LABEL USE 2238
2 RHEUMATOID ARTHRITIS 2133
3 DRUG INTOLERANCE 1973
4 PAIN 1911
5 SYNOVITIS 1815
6 JOINT SWELLING 1781
7 FATIGUE 1762
8 RASH 1762
9 ARTHRALGIA 1709
See all common reactions for TOFACITINIB

TOFACITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRONCHIAL ATRESIA 5 0.7143
1 HEPATIC ENZYME 75 0.5034
2 THIOPURINE METHYLTRANSFERASE DECREASED 17 0.5000
3 ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA 10 0.2941
4 HYPOCHOLESTEROLAEMIA 98 0.2776
5 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 6 0.2609
6 SWOLLEN JOINT COUNT INCREASED 722 0.2262
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1410 0.1966
8 LUPUS VULGARIS 242 0.1921
9 RHEUMATIC FEVER 846 0.1896
See all enriched reactions for TOFACITINIB